15 Feb 2025, virtual. Dr Vernadou will participate in the 16th Post-Training Seminar of Clinical & Research Oncology, where she will give a lecture at the Round Table: “Breast cancer: personalized approach from diagnosis to treatment”. [...]

20-21 February 2025, Brussels. Dr Razis will participate in the EORTC Brain Tumor Group steering committee meeting and General Assembly, which will take place in Brussels. [...]

February 18, 2025, 14:00-15:30, Athens. Dr Razis will deliver a lecture to the Neurology residents at the University Neurology Department on the: “Molecular classification of brain tumors”. [...]

12 February 2025, 19:00, virtual. Dr Razis will preside virtually at the ASCO Project ECHO on the topic: “Breast Cancer Survivorship for Primary Care physicians”. At this session Dr Vernadou will present a case from our department. [...]

9 February 2025, 10:00-13:30, virtual. Dr Razis, Dr Lambropoulos and Dr Rigakos will participate virtually in the 2nd Educational Seminar of the cycle titled: “Sarcoma, Melanoma, CNS Tumors, NETs, Rare Tumors”, organized by the Association of Medical Oncologists of Greece. [...]

22 January 2024, Zurich, 11:00-11:30. Dr Razis will participate as an invited speaker at the 6th Symposium on Brain Metastases organized by the Comprehensive Cancer Center Zürich, where she will give a lecture titled: “Medical challenges for CNS metastases”. [...]

November 15-24, 2024, Texas, America. Dr Razis will participate in the 29th Annual Neuro-oncology Conference 2024, which will be held in Houston, Texas. At this conference she will present a poster titled: “European Neuro-Oncology Quality Assurance (ENOQUA): An EORTC brain [...]

November 6th, 2024, Brussels, Belgium. Dr Razis in the context of the 25th anniversary of the Breast International Group (BIG), will participate in the round table discussion that will take place in Brussels in the presence of the Queen of [...]

The Contemporary Oncology Team (COT) is the first non-US oncology group to be certified by ASCO’s new quality control program, “ASCO Certified”. Achieving this certification demonstrates COT’s strong and ongoing commitment to assessing the quality of oncology care it offers, [...]